Understanding the Long-term Impact of COVID-19 in Adults (RECOVER)
NIH RECOVER: A Multi-site Observational Study of Post-Acute Sequelae of SARS-CoV-2 Infection in Adults
1 other identifier
observational
15,172
2 countries
86
Brief Summary
This is a combined retrospective and prospective, longitudinal, observational meta-cohort of individuals who will enter the cohort with and without SARS-CoV-2 infection and at varying stages before and after infection. Individuals with and without SARS-CoV-2 infection and with or without Post-Acute Sequelae of COVID-19 (PASC) symptoms will be followed to identify risk factors and occurrence of PASC. This study will be conducted in the United States and subjects will be recruited through inpatient, outpatient, and community-based settings. Study data including age, demographics, social determinants of health, medical history, vaccination history, details of acute SARS-CoV-2 infection, overall health and physical function, and PASC symptom screen will be reported by subjects or collected from the electronic health record using a case report form at specified intervals. Biologic specimens will be collected at specified intervals, with some tests performed in local clinical laboratories and others performed by centralized research centers or banked in the Biospecimen Repository. Advanced clinical examinations and radiologic examinations will be performed at local study sites with cross-site standardization.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2021
Longer than P75 for all trials
86 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 29, 2021
CompletedFirst Submitted
Initial submission to the registry
December 27, 2021
CompletedFirst Posted
Study publicly available on registry
December 29, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2025
CompletedDecember 15, 2025
December 1, 2025
4 years
December 27, 2021
December 10, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Incidence of candidate PASC symptoms over time
Up to 4 Years
Prevalence of candidate PASC symptoms over time
Up to 4 Years
Secondary Outcomes (2)
Incidence of organ injury
Up to 4 Years
Incidence of clinical disease
Up to 4 Years
Study Arms (2)
Participants with SARS-CoV-2 Infection
Participants without SARS-CoV-2 Infection
Eligibility Criteria
Infected: Individuals at least 18 years of age meet WHO criteria for suspected, probable or confirmed SARS-CoV-2 infection on or after March 1, 2020. Uninfected: Individuals at least 18 years of age who have never met any of the WHO criteria for suspected, probable or confirmed SARS-CoV-2 infection.
You may qualify if:
- INFECTED COHORT -- ADULTS WITH SUSPECTED SARS-COV-2 INFECTION --
- An adult qualifies as having suspected SARS-CoV-2 infection if meeting criteria a, b or c below:
- Patients who meet the following clinical criteria plus one of the epidemiological criteria:
- Clinical Criteria: Acute onset of fever and cough OR acute onset of any three of more of the following signs or symptoms: fever, cough, general weakness /fatigue, headache, myalgia, sore throat, coryza, dyspnea, anorexia/nausea/vomiting, diarrhea, altered mental status.
- Epidemiological Criteria:
- Residing or working in an area with a high risk of transmission of virus: closed residential settings, humanitarian settings such as camp and camp-like settings for displaced persons; anytime within the 14 days before symptom onset; or
- Residing or travel to an area with community transmission anytime within the 14 days before symptom onset; or
- Working in any health care setting, including within health facilities or within the community; anytime within the 14 days before symptom onset.
- A patient with severe acute respiratory illness: (acute respiratory infection with history of fever or measured fever of ≥38C°; and cough; with onset within the last 10 days; and requires hospitalization).
- An asymptomatic person not meeting epidemiologic criteria with a positive SARS-CoV-2 Antigen-RDT.
- ADULTS WITH PROBABLE SARS-COV-2 INFECTION --
- An adult qualifies as having probable SARS-CoV-2 infection if meeting any one of a-d below:
- A patient who meets clinical criteria for suspected SARS-CoV-2 AND is a contact of a probable or confirmed case or linked to a COVID-19 cluster;
- A suspect case with chest imaging showing findings suggestive of COVID-19 disease;
- A person with recent onset of anosmia (loss of smell) or ageusia (loss of taste) in the absence of any other identified cause;
- +15 more criteria
You may not qualify if:
- Individuals who have not yet reached the age of majority
- Unable to provide consent
- Individuals in hospice care
- Any serious medical condition which would prevent long-term participation
- Individuals participating in the study NIH RECOVER-Pediatric: Understanding the long-term impact of COVID on children and families
- Incarcerated individuals
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (86)
University of Alabama at Birmingham (Pregnancy Cohort)
Birmingham, Alabama, 35294, United States
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
University of South Alabama
Mobile, Alabama, 36688, United States
Banner University Medical Center (BUMC) - Phoenix
Phoenix, Arizona, 85006, United States
University of Arizona
Tucson, Arizona, 85724, United States
Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
University of California San Francisco (Pregnancy Cohort)
San Francisco, California, 94115, United States
University of California, San Francisco (UCSF)
San Francisco, California, 94143, United States
Stanford University
Stanford, California, 94305, United States
Denver Health and Hospital Authority
Denver, Colorado, 80204, United States
University of Colorado Denver
Denver, Colorado, 80204, United States
Yale School of Medicine (YSM)
New Haven, Connecticut, 06510, United States
ChristianaCare Health System
Newark, Delaware, 19718, United States
George Washington University
Washington D.C., District of Columbia, 20052, United States
Howard University
Washington D.C., District of Columbia, 20059, United States
Kaiser Permanente Georgia
Atlanta, Georgia, 30305, United States
Morehouse School of Medicine (MSM)
Atlanta, Georgia, 30310, United States
Emory University
Atlanta, Georgia, 30322, United States
University of Hawai'i - Mānoa's John A. Burns School of Medicine
Honolulu, Hawaii, 96822, United States
University of Illinois at Chicago
Chicago, Illinois, 60608, United States
Northwestern University
Evanston, Illinois, 60208, United States
Northshore University HealthSystem
Glenview, Illinois, 60026, United States
University of Kansas Medical Center (KUMC)
Kansas City, Kansas, 66160, United States
University of Kentucky
Lexington, Kentucky, 40506, United States
Louisiana State University - Pennington Biomedical Research Center
Baton Rouge, Louisiana, 70808, United States
Louisiana State University (LSU)
New Orleans, Louisiana, 70112, United States
University Medical Center New Orleans
New Orleans, Louisiana, 70112, United States
Ochsner Health System
New Orleans, Louisiana, 70115, United States
Tulane University
New Orleans, Louisiana, 70118, United States
MaineHealth
Portland, Maine, 04101, United States
Tufts Medical Center
Boston, Massachusetts, 02111, United States
Mass General Brigham - Harvard University
Boston, Massachusetts, 02114, United States
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Harvard Medical School
Boston, Massachusetts, 02115, United States
Harvard School Of Public Health
Boston, Massachusetts, 02115, United States
Beth Israel Deaconess Medical Center (BIDMC)
Boston, Massachusetts, 02215, United States
Boston University
Boston, Massachusetts, 02215, United States
Cambridge Health Alliance (CHA)
Cambridge, Massachusetts, 02139, United States
Mayo Clinic
Rochester, Minnesota, 55905, United States
University of Mississippi Medical Center (UMMC)
Jackson, Mississippi, 39216, United States
University Of Nebraska Medical Center
Omaha, Nebraska, 68198, United States
Saint Peter's University Hospital
New Brunswick, New Jersey, 08901, United States
University of New Mexico Health Sciences Center
Albuquerque, New Mexico, 87102, United States
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
Columbia University (Pregnancy)
New York, New York, 10032, United States
Columbia University
New York, New York, 10032, United States
NewYork-Presbyterian Hospital
Queens, New York, 11355, United States
University of North Carolina (UNC) at Chapel Hill
Chapel Hill, North Carolina, 27516, United States
Duke University Medical Center
Durham, North Carolina, 27710, United States
WakeMed Health & Hospitals
Raleigh, North Carolina, 27610, United States
University of North Dakota
Grand Forks, North Dakota, 58202, United States
Good Samaritan Hospital
Cincinnati, Ohio, 45220, United States
Case Western Reserve University
Cleveland, Ohio, 44106, United States
University Hospitals MacDonald's Women's Hospital
Cleveland, Ohio, 44106, United States
Metrohealth System
Cleveland, Ohio, 44109, United States
The MetroHealth System (Pregnancy Cohort)
Cleveland, Ohio, 44109, United States
The Ohio State University - Wexner Medical Center
Columbus, Ohio, 43210, United States
Miami Valley Hospital
Dayton, Ohio, 45409, United States
University of Oklahoma Health Sciences Center (OUHSC)
Oklahoma City, Oklahoma, 73104, United States
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
University of Pittsburgh Medical Center (UPMC)
Pittsburgh, Pennsylvania, 15213, United States
Women & Infants Hospital
Providence, Rhode Island, 02905, United States
Prisma Health Upstate
Greenville, South Carolina, 29605, United States
Sanford Health
Sioux Falls, South Dakota, 57106, United States
St. David's Health Care
Austin, Texas, 78758, United States
University of Texas Medical Branch (UTMB) Galveston
Galveston, Texas, 77555, United States
Memorial Hermann Health System
Houston, Texas, 77024, United States
University of Texas Health Science Center at Houston
Houston, Texas, 77024, United States
UTMB Health League City Campus Hospital & Clinics
League City, Texas, 77573, United States
University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78229, United States
McKay-Dee Hospital
Ogden, Utah, 84403, United States
Utah Valley Regional Medical Center
Provo, Utah, 84604, United States
Bateman Horne Center
Salt Lake City, Utah, 84102, United States
Intermountain Medical Center (Intermountain Healthcare)
Salt Lake City, Utah, 84107, United States
University of Utah
Salt Lake City, Utah, 84112, United States
University of Utah Health
Salt Lake City, Utah, 84132, United States
LDS Hospital - Intermountain Healthcare
Salt Lake City, Utah, 84143, United States
Providence Regional Medical Center Everett
Everett, Washington, 98201, United States
University of Washington
Seattle, Washington, 98104, United States
Institute for Systems Biology (ISB)
Seattle, Washington, 98109, United States
Swedish Medical Center
Seattle, Washington, 98109, United States
Providence Sacred Heart Medical Center
Spokane, Washington, 99204, United States
West Virginia University
Morgantown, West Virginia, 26506, United States
Medical College Of Wisconsin
Milwaukee, Wisconsin, 53226, United States
Hispanic Alliance for Clinical and Translational Research
San Juan, 00927, Puerto Rico
Related Publications (5)
Kulik GL, Zheng T, Jolley SE, Ashktorab H, Brim H, Feuerriegel EM, Hafner JW, Hess R, Horne BD, Hornig M, Johnson B, Kim C, Laiyemo AO, McComsey GA, Nikolich JZ, Reid K, Scherry J, Sherif ZA, Tran HG, Verduzco-Gutierrez M, West S, Erlandson KM; RECOVER Adult Cohort Consortium. Physical Function Differences by COVID-19 Status: A Cross-sectional Analysis From the RECOVER Adult Cohort. Phys Ther. 2025 Jul 1;105(7):pzaf063. doi: 10.1093/ptj/pzaf063.
PMID: 40302048DERIVEDErlandson KM, Geng LN, Selvaggi CA, Thaweethai T, Chen P, Erdmann NB, Goldman JD, Henrich TJ, Hornig M, Karlson EW, Katz SD, Kim C, Cribbs SK, Laiyemo AO, Letts R, Lin JY, Marathe J, Parthasarathy S, Patterson TF, Taylor BD, Duffy ER, Haack M, Julg B, Maranga G, Hernandez C, Singer NG, Han J, Pemu P, Brim H, Ashktorab H, Charney AW, Wisnivesky J, Lin JJ, Chu HY, Go M, Singh U, Levitan EB, Goepfert PA, Nikolich JZ, Hsu H, Peluso MJ, Kelly JD, Okumura MJ, Flaherman VJ, Quigley JG, Krishnan JA, Scholand MB, Hess R, Metz TD, Costantine MM, Rouse DJ, Taylor BS, Goldberg MP, Marshall GD, Wood J, Warren D, Horwitz L, Foulkes AS, McComsey GA; RECOVER-Adult Cohort. Differentiation of Prior SARS-CoV-2 Infection and Postacute Sequelae by Standard Clinical Laboratory Measurements in the RECOVER Cohort. Ann Intern Med. 2024 Sep;177(9):1209-1221. doi: 10.7326/M24-0737. Epub 2024 Aug 13.
PMID: 39133923DERIVEDMetz TD, Reeder HT, Clifton RG, Flaherman V, Aragon LV, Baucom LC, Beamon CJ, Braverman A, Brown J, Cao T, Chang A, Costantine MM, Dionne JA, Gibson KS, Gross RS, Guerreros E, Habli M, Hadlock J, Han J, Hess R, Hillier L, Hoffman MC, Hoffman MK, Hughes BL, Jia X, Kale M, Katz SD, Laleau V, Mallett G, Mehari A, Mendez-Figueroa H, McComsey GA, Monteiro J, Monzon V, Okumura MJ, Pant D, Pacheco LD, Palatnik A, Palomares KTS, Parry S, Pettker CM, Plunkett BA, Poppas A, Ramsey P, Reddy UM, Rouse DJ, Saade GR, Sandoval GJ, Sciurba F, Simhan HN, Skupski DW, Sowles A, Thorp JM Jr, Tita ATN, Wiegand S, Weiner SJ, Yee LM, Horwitz LI, Foulkes AS, Jacoby V; NIH Researching COVID to Enhance Recovery (RECOVER) Consortium*. Post-Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) After Infection During Pregnancy. Obstet Gynecol. 2024 Sep 1;144(3):411-420. doi: 10.1097/AOG.0000000000005670. Epub 2024 Jul 11.
PMID: 38991216DERIVEDHorwitz LI, Thaweethai T, Brosnahan SB, Cicek MS, Fitzgerald ML, Goldman JD, Hess R, Hodder SL, Jacoby VL, Jordan MR, Krishnan JA, Laiyemo AO, Metz TD, Nichols L, Patzer RE, Sekar A, Singer NG, Stiles LE, Taylor BS, Ahmed S, Algren HA, Anglin K, Aponte-Soto L, Ashktorab H, Bassett IV, Bedi B, Bhadelia N, Bime C, Bind MC, Black LJ, Blomkalns AL, Brim H, Castro M, Chan J, Charney AW, Chen BK, Chen LQ, Chen P, Chestek D, Chibnik LB, Chow DC, Chu HY, Clifton RG, Collins S, Costantine MM, Cribbs SK, Deeks SG, Dickinson JD, Donohue SE, Durstenfeld MS, Emery IF, Erlandson KM, Facelli JC, Farah-Abraham R, Finn AV, Fischer MS, Flaherman VJ, Fleurimont J, Fonseca V, Gallagher EJ, Gander JC, Gennaro ML, Gibson KS, Go M, Goodman SN, Granger JP, Greenway FL, Hafner JW, Han JE, Harkins MS, Hauser KSP, Heath JR, Hernandez CR, Ho O, Hoffman MK, Hoover SE, Horowitz CR, Hsu H, Hsue PY, Hughes BL, Jagannathan P, James JA, John J, Jolley S, Judd SE, Juskowich JJ, Kanjilal DG, Karlson EW, Katz SD, Kelly JD, Kelly SW, Kim AY, Kirwan JP, Knox KS, Kumar A, Lamendola-Essel MF, Lanca M, Lee-Lannotti JK, Lefebvre RC, Levy BD, Lin JY, Logarbo BP Jr, Logue JK, Longo MT, Luciano CA, Lutrick K, Malakooti SK, Mallett G, Maranga G, Marathe JG, Marconi VC, Marshall GD, Martin CF, Martin JN, May HT, McComsey GA, McDonald D, Mendez-Figueroa H, Miele L, Mittleman MA, Mohandas S, Mouchati C, Mullington JM, Nadkarni GN, Nahin ER, Neuman RB, Newman LT, Nguyen A, Nikolich JZ, Ofotokun I, Ogbogu PU, Palatnik A, Palomares KTS, Parimon T, Parry S, Parthasarathy S, Patterson TF, Pearman A, Peluso MJ, Pemu P, Pettker CM, Plunkett BA, Pogreba-Brown K, Poppas A, Porterfield JZ, Quigley JG, Quinn DK, Raissy H, Rebello CJ, Reddy UM, Reece R, Reeder HT, Rischard FP, Rosas JM, Rosen CJ, Rouphael NG, Rouse DJ, Ruff AM, Saint Jean C, Sandoval GJ, Santana JL, Schlater SM, Sciurba FC, Selvaggi C, Seshadri S, Sesso HD, Shah DP, Shemesh E, Sherif ZA, Shinnick DJ, Simhan HN, Singh U, Sowles A, Subbian V, Sun J, Suthar MS, Teunis LJ, Thorp JM Jr, Ticotsky A, Tita ATN, Tragus R, Tuttle KR, Urdaneta AE, Utz PJ, VanWagoner TM, Vasey A, Vernon SD, Vidal C, Walker T, Ward HD, Warren DE, Weeks RM, Weiner SJ, Weyer JC, Wheeler JL, Whiteheart SW, Wiley Z, Williams NJ, Wisnivesky JP, Wood JC, Yee LM, Young NM, Zisis SN, Foulkes AS. Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design. PLoS One. 2023 Jun 23;18(6):e0286297. doi: 10.1371/journal.pone.0286297. eCollection 2023.
PMID: 37352211DERIVEDMetz TD, Clifton RG, Gallagher R, Gross RS, Horwitz LI, Jacoby VL, Martin-Herz SP, Peralta-Carcelen M, Reeder HT, Beamon CJ, Bind MA, Chan J, Chang AA, Chibnik LB, Costantine MM, Fitzgerald ML, Foulkes AS, Gibson KS, Guthe N, Habli M, Hackney DN, Hoffman MK, Hoffman MC, Hughes BL, Katz SD, Laleau V, Mallett G, Mendez-Figueroa H, Monzon V, Palatnik A, Palomares KTS, Parry S, Peralta-Carcelen M, Pettker CM, Plunkett BA, Poppas A, Reddy UM, Rouse DJ, Saade GR, Sandoval GJ, Schlater SM, Sciurba FC, Simhan HN, Skupski DW, Sowles A, Thaweethai T, Thomas GL, Thorp JM Jr, Tita AT, Weiner SJ, Weigand S, Yee LM, Flaherman VJ. Researching COVID to enhance recovery (RECOVER) pregnancy study: Rationale, objectives and design. medRxiv [Preprint]. 2023 Apr 24:2023.04.24.23289025. doi: 10.1101/2023.04.24.23289025.
PMID: 37162923DERIVED
Biospecimen
Nasal swabs in freeze medium, blood, saliva, stool and urine. For patients undergoing Tier 3 invasive testing through additional consent, or undergoing additional tests as part of routine clinical care, residual samples collected for clinical purposes will whenever possible be collected and sent to the biospecimen core, including: cerebrospinal fluid (CSF), biopsy specimens, bronchoalveolar lavage (BAL), lymph node aspirants
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stuart Katz, MD, MS
NYU Langone Health
- PRINCIPAL INVESTIGATOR
Leora Horwitz, MD
NYU Langone Health
- PRINCIPAL INVESTIGATOR
Andrea Troxel, ScD
NYU Langone Health
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 27, 2021
First Posted
December 29, 2021
Study Start
October 29, 2021
Primary Completion
October 31, 2025
Study Completion
October 31, 2025
Last Updated
December 15, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- Beginning 9 months and no end date.
- Access Criteria
- The investigator who proposed to use the data and investigators whose proposed use of the data has been approved by an independent review committee ("learned intermediary") identified for this purpose will have access to the data upon reasonable request. Requests should be directed to RECOVER\ CSC@NYULangone.org. To gain access, data requestors will need to sign a data access agreement.
Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices) will be shared upon reasonable request.